| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Sales | 729,394 | 409,268 | 341,264 | 554,908 |
| Cost of sales (excluding depreciation expense) | 293,838 | 158,171 | 117,266 | 190,839 |
| Research and development | 1,382,022 | 1,414,429 | 2,968,472 | 2,303,241 |
| Sales and marketing | 1,143,805 | 984,977 | 908,567 | 1,572,189 |
| General and administrative | 1,477,800 | 1,616,972 | 1,722,713 | 1,530,791 |
| Depreciation and amortization | 85,697 | 86,285 | 84,853 | 76,288 |
| Total operating expenses | 4,089,324 | 4,102,663 | 5,684,605 | 5,482,509 |
| Loss from operations | -3,653,768 | -3,851,566 | -5,460,607 | -5,118,440 |
| Interest income | 17,315 | 17,144 | 19,029 | 124,028 |
| Interest expense | 532,073 | 491,500 | 459,449 | 413,290 |
| Other expense | -26,295 | -260,000 | - | - |
| Total other expense, net | -541,053 | -734,356 | -440,420 | -289,262 |
| Loss before income taxes | -4,194,821 | -4,585,922 | -5,901,027 | -5,407,702 |
| Income tax expense (benefit) | 0 | 0 | -4,188 | 1,158 |
| Net loss | -4,194,821 | -4,585,922 | -5,896,839 | -5,408,860 |
| Net loss per share attributable to common stockholders, basic (in dollars per share) | -0.1 | -0.16 | -0.23 | -0.24 |
| Net loss per share attributable to common stockholders, diluted (in dollars per share) | -0.1 | -0.16 | -0.23 | -0.24 |
| Weighted-average shares used in computing net loss per share attributable to common stockholders, basic (in shares) | 41,015,196 | 28,880,704 | 25,149,236 | 22,232,799 |
| Weighted-average shares used in computing net loss per share attributable to common stockholders, diluted (in shares) | 41,015,196 | 28,880,704 | 25,149,236 | 22,232,799 |
FEMASYS INC (FEMY)
FEMASYS INC (FEMY)